{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:40:22Z","timestamp":1778539222393,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"am","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.anai.2023.01.025","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T21:32:05Z","timestamp":1675287125000},"page":"743-751.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antibody and T-cell responses to coronavirus disease 2019 vaccination in common variable immunodeficiency and specific antibody deficiency"],"prefix":"10.1016","volume":"130","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2160-8835","authenticated-orcid":false,"given":"Jamie A.","family":"Rosenthal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle Premazzi","family":"Papa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Nicholes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carissa S.","family":"Holmberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Bosque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjeni","family":"Keswani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Amdur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca M.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Soriano-Sarabia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Ein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7830","key":"10.1016\/j.anai.2023.01.025_bib0001","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41586-020-2639-4","article-title":"Phase I\/II study of COVID-19 RNA vaccine BNT162b1 in adults","volume":"586","author":"Mulligan","year":"2020","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.anai.2023.01.025_bib0002","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"mRNA-1273 Study Group. An mRNA Vaccine against SARS-CoV-2 - Preliminary","volume":"383","author":"Jackson","year":"2020","journal-title":"N Engl J Med"},{"issue":"7830","key":"10.1016\/j.anai.2023.01.025_bib0003","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-020-2814-7","article-title":"COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses","volume":"586","author":"Sahin","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.anai.2023.01.025_bib0004","doi-asserted-by":"crossref","first-page":"76","DOI":"10.20411\/pai.v6i1.435","article-title":"COVID-19 outcomes in patients undergoing B cell depletion therapy and those with humoral immunodeficiency states: a scoping review","volume":"6","author":"Jones","year":"2021","journal-title":"Pathog Immun"},{"issue":"3","key":"10.1016\/j.anai.2023.01.025_bib0005","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/iid3.450","article-title":"COVID-19 infection in CVID patients: what we know so far","volume":"9","author":"Weifenbach","year":"2021","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.anai.2023.01.025_bib0006","doi-asserted-by":"crossref","DOI":"10.1177\/21526575221096044","article-title":"COVID-19 infection in patients with humoral immunodeficiency: a case series and literature review","volume":"13","author":"Jalil","year":"2022","journal-title":"Allergy Rhinol (Providence)"},{"issue":"1","key":"10.1016\/j.anai.2023.01.025_bib0007","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jaip.2020.09.052","article-title":"Clinical outcomes and features of COVID-19 in patients with primary immunodeficiencies in New York City","volume":"9","author":"Ho","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2023.01.025_bib0008","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jaci.2020.12.620","article-title":"UK PIN COVID-19 consortium. COVID-19 in patients with primary and secondary immunodeficiency: the United Kingdom experience","volume":"147","author":"Shields","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.01.025_bib0009","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/clim.1999.4799","article-title":"Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan American Group for immunodeficiency) and ESID (European Society for Immunodeficiencies)","volume":"93","author":"Conley","year":"1999","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.01.025_bib0011","doi-asserted-by":"crossref","first-page":"14","DOI":"10.18176\/jiaci.0388","article-title":"Common variable immunodeficiency: epidemiology, pathogenesis, clinical manifestations, diagnosis, classification, and management","volume":"30","author":"Yazdani","year":"2020","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"3 suppl","key":"10.1016\/j.anai.2023.01.025_bib0010","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2012.07.002","article-title":"Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology","volume":"130","author":"Orange","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.01.025_bib0012","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jaci.2021.05.029","article-title":"Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity","volume":"148","author":"Hagin","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2023.01.025_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.827048","article-title":"Antigen-specific CD4+ T-cell activation in primary antibody deficiency after BNT162b2 mRNA COVID-19 vaccination","volume":"13","author":"Sauerwein","year":"2022","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.anai.2023.01.025_bib0014","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s10875-021-01133-0","article-title":"SARS-CoV-2 vaccine induced atypical immune responses in antibody defects: everybody does their best","volume":"41","author":"Salinas","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.anai.2023.01.025_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.727850","article-title":"Humoral and cellular response following vaccination with the BNT162b2 mRNA COVID-19 vaccine in patients affected by primary immunodeficiencies","volume":"12","author":"Amodio","year":"2021","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.anai.2023.01.025_bib0016","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.jaci.2022.04.002","article-title":"Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity","volume":"149","author":"Van Leeuwen","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.01.025_bib0017","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jaci.2021.11.022","article-title":"Immunogenicity and tolerability of COVID-19 messenger RNA vaccines in primary immunodeficiency patients with functional B-cell defects","volume":"149","author":"Pham","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.01.025_bib0018","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","article-title":"International consensus document (ICON): common variable immunodeficiency disorders","volume":"4","author":"Bonilla","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"27","key":"10.1016\/j.anai.2023.01.025_bib0019","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"C4591001 clinical trial group. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.anai.2023.01.025_bib0020","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.anai.2023.01.025_bib0021","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1007\/s10875-021-01046-y","article-title":"Robust antibody and T cell responses to SARS-CoV-2 in patients with antibody deficiency","volume":"41","author":"Kinoshita","year":"2021","journal-title":"J Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2023.01.025_bib0022","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.anai.2021.07.021","article-title":"Specific antibody response of patients with common variable immunodeficiency to BNT162b2 coronavirus disease 2019 vaccination","volume":"127","author":"Abo-Helo","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.01.025_bib0023","first-page":"159","article-title":"Study of B and T cell phenotypes in blood from patients with common variable immunodeficiency (CVID)","volume":"5","author":"Farrant","year":"1994","journal-title":"Immunodeficiency"},{"issue":"6","key":"10.1016\/j.anai.2023.01.025_bib0024","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.4049\/jimmunol.178.6.3932","article-title":"Unravelling the complexity of T cell abnormalities in common variable immunodeficiency","volume":"178","author":"Giovannetti","year":"2007","journal-title":"J Immunol"},{"issue":"7875","key":"10.1016\/j.anai.2023.01.025_bib0025","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41586-021-03841-4","article-title":"Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine","volume":"597","author":"Oberhardt","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.anai.2023.01.025_bib0026","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1046\/j.1365-2249.1999.00946.x","article-title":"CD95 expression and function on lymphocyte subpopulations in common variable immunodeficiency (CVID); related to increased apoptosis","volume":"117","author":"Iglesias","year":"1999","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.01.025_bib0027","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.clim.2005.11.011","article-title":"CD8+HLA-DR+ T lymphocytes are increased in common variable immunodeficiency patients with impaired memory B-cell differentiation","volume":"119","author":"Viallard","year":"2006","journal-title":"Clin Immunol"},{"key":"10.1016\/j.anai.2023.01.025_bib0028","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4951587","article-title":"Common variable immunodeficiency and circulating TFH","volume":"2016","author":"Coraglia","year":"2016","journal-title":"J Immunol Res"},{"issue":"6","key":"10.1016\/j.anai.2023.01.025_bib0029","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s10875-022-01296-4","article-title":"Defining clinical and immunological predictors of poor immune responses to COVID-19 mRNA vaccines in patients with primary antibody deficiency","volume":"42","author":"Shin","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.anai.2023.01.025_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103539","article-title":"B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19","volume":"70","author":"Zollner","year":"2021","journal-title":"EBiomedicine"},{"issue":"12","key":"10.1016\/j.anai.2023.01.025_bib0031","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.3390\/cells11121918","article-title":"T-cell defects associated to lack of spike-specific antibodies after BNT162b2 full immunization followed by a booster dose in patients with common variable immune deficiencies","volume":"11","author":"Pulvirenti","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.anai.2023.01.025_bib0032","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1146\/annurev.immunol.021908.132557","article-title":"Blood monocytes: development, heterogeneity, and relationship with dendritic cells","volume":"27","author":"Auffray","year":"2009","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"10.1016\/j.anai.2023.01.025_bib0033","first-page":"449","article-title":"T- helper 1 and 2 cytokine assay in patients with common variable immunodeficiency","volume":"18","author":"Rezaei","year":"2008","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.01.025_bib0034","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2165\/00063030-200519010-00007","article-title":"Modulating effects of intravenous immunoglobulins on serum cytokine levels in patients with primary hypogammaglobulinemia","volume":"19","author":"Ib\u00e1\u00f1ez","year":"2005","journal-title":"BioDrugs"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120623000777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120623000777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:32:41Z","timestamp":1761053561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120623000777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1081120623000777"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2023.01.025","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody and T-cell responses to coronavirus disease 2019 vaccination in common variable immunodeficiency and specific antibody deficiency","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2023.01.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}